Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Hemophilia Gene Therapies Should Have REMS For Approval, National Hemophilia Foundation Says
Jul 13 2022
•
By
Brenda Sandburg
National Hemophilia Foundation wants restrictions on use of gene therapies to mitigate risk • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Cell & Gene Therapies
More from Advanced Technologies